These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3562976)

  • 21. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease.
    Puri RD; Tewari S; Sinha N; Ramesh V; Khan F; Singh VP; Agrawal S
    Indian Heart J; 2003; 55(1):60-4. PubMed ID: 12760590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between sex hormones and lipid profile in men with coronary artery disease.
    Wranicz JK; Cygankiewicz I; Rosiak M; Kula P; Kula K; Zareba W
    Int J Cardiol; 2005 May; 101(1):105-10. PubMed ID: 15860391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipids and lipoproteins in women.
    Sattler AM; Soufi M; Maisch B; Schaefer JR
    Herz; 2005 Aug; 30(5):368-74; quiz 429-30. PubMed ID: 16132239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease.
    Toschi V
    J Thromb Haemost; 2007 Mar; 5(3):472-4. PubMed ID: 17319902
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipoprotein Subfractions in Type 2 Diabetes.
    Roever L; Resende ES; Alpert JS
    Heart Lung Circ; 2017 Mar; 26(3):209-210. PubMed ID: 28087153
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H; Isbir T; Agachan B; Karaali ZE
    Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individuality of lipemic responses to diet.
    McGill HC; Kushwaha RS
    Can J Cardiol; 1995 Oct; 11 Suppl G():15G-27G. PubMed ID: 7585289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombogenic and atherogenic lipid modifications in plasma and patients with coronary artery disease and after coronary artery bypass surgery.
    Kovacs IB; Jahangiri M; Ridler CD; Görög P; Rees GM
    Rinsho Byori; 1998 Jul; 46(7):656-62. PubMed ID: 9758553
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoprotein (a) phenotypes in south Indian patients with coronary artery disease.
    Geethanjali FS; Jose VJ; Kanagasabapathy AS
    Indian Heart J; 2002; 54(1):50-3. PubMed ID: 11999088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma fatty acids, lipids, lipoprotein and macroangiopathy].
    Ninomiya K; Maruhama Y
    Rinsho Byori; 1995 May; 43(5):449-53. PubMed ID: 7783361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipoproteins and coronarographic features.
    Graziani MS; Lippi U; Vassanelli C
    Clin Chem; 1989 Jun; 35(6):1266-7. PubMed ID: 2731357
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].
    Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
    Cybulska B
    Kardiol Pol; 2005 Feb; 62(2):153-6. PubMed ID: 15815801
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lipoprotein indexes in coronary atheromatosis].
    Pintó Sala J; Fiol Castaño C; Bros Caimari R; Marcos Vidal C
    Rev Clin Esp; 1987 Jan; 180(1):59-60. PubMed ID: 3562976
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis.
    Lima LM; Sousa MO; Dusse LM; Lasmar MC; das Graças Carvalho M; Lwaleed BA
    Thromb Res; 2007; 121(2):283-7. PubMed ID: 17582470
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.